These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands. Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM. Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723 [Abstract] [Full Text] [Related]
3. [Beta subunit of chorionic gonadotropin in the control of benign trophoblastic disease]. Vargas López E, Cano Vargas CE, Vázquez Matute LH, Aldana Bustamante A, Santini Villar AJ. Ginecol Obstet Mex; 1982 Jan; 50(297):4-7. PubMed ID: 6292056 [No Abstract] [Full Text] [Related]
4. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole. Elmer DB, Granai CO, Ball HG, Curry SL. Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320 [Abstract] [Full Text] [Related]
5. Persistent trophoblast disease following partial molar pregnancy. Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M. Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033 [Abstract] [Full Text] [Related]
7. Localization of HCG alpha and HCG beta in trophoblastic tumors. Kawagoe K, Mori S. Asia Oceania J Obstet Gynaecol; 1984 Mar; 10(1):111-7. PubMed ID: 6203510 [No Abstract] [Full Text] [Related]
8. Detection of hCG in trophoblastic disease. The USA hCG reference service experience. Cole LA, Butler S. J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011 [Abstract] [Full Text] [Related]
9. Serum levels of macrophage colony-stimulating factor in trophoblastic disease. Kohorn EI, Kacinski BM, Stanley ER. Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936 [Abstract] [Full Text] [Related]
11. Structures, function, and transformational changes of the sugar chains of glycohormones. Kobata A. J Cell Biochem; 1988 May; 37(1):79-90. PubMed ID: 2839526 [Abstract] [Full Text] [Related]
12. The hCG assay in the treatment of trophoblastic disease. Pattillo RA, Hussa RO. J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684 [Abstract] [Full Text] [Related]
13. [An immunohistochemical study in conjunction with the enzyme labelled antibody method to discern the relevancy between the localization of hCG, hPL and the functions of the normal and malignant trophoblast (author's transl)]. Tanaka A. Nihon Sanka Fujinka Gakkai Zasshi; 1982 May; 34(5):579-88. PubMed ID: 6282995 [No Abstract] [Full Text] [Related]
14. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy. Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E. Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768 [Abstract] [Full Text] [Related]
15. Thyrotropic activity of acidic isoelectric variants of human chorionic gonadotropin from trophoblastic tumors. Mann K, Schneider N, Hoermann R. Endocrinology; 1986 Apr; 118(4):1558-66. PubMed ID: 3004921 [Abstract] [Full Text] [Related]
16. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer. Cole LA, Sutton JM. J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826 [Abstract] [Full Text] [Related]
17. Disease of the trophoblast. Ratnam SS, Ilancheran A. Clin Obstet Gynaecol; 1982 Dec; 9(3):539-64. PubMed ID: 6293752 [Abstract] [Full Text] [Related]
18. [Studies on enzymeimmunoassay for human chorionic gonadotropin and its clinical application]. Kobayashi O, Shirotake S, Takamizawa H. Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jun; 35(6):764-72. PubMed ID: 6308107 [Abstract] [Full Text] [Related]